13. Parallel Importation Flashcards
L’Oreal v eBay (samples)
samples supplied free of charge is not putting on market
Zino Davidoff
CONSENT CAN BE IMPLIED BUT VERY DIFFICULT
- implied only if “unequivocally demonstrated” intention to renounce rights
- can’t imply from silence or lack of statement saying no import to EEA
Master cigars v Hunters
CONSENT to import in EEA unequivocally demonstrated
- limit on sales in Cuba was well beyond personal use
- parties involved knew of import (parties wanted hard currency in Cuba, and invoices in German)
Failure to police importation is not enough
BUT here, C facilitated importation
Copad v Dior (exhaustion)
NO exhaustion if marketing occurred in breach of a license (consent only given for specific batch)
marketing is NOT with consent if breach of license re:
- duration
- form of TM
- scope of g/s
- territory
- quality
L’Oreal v Ebay (depackaging)
sale with without packaging = legitimate reason to oppose if
- essential information missing (i..e who is manufacturer)
- damage to image of product and this mark
Bristol-Myers Squibb v Paranova
repackaging = legitimate reason to oppose (s.7(2))
because it jeopardises guarantee of origin
- presumption = can oppose (inherent risk to goods so legitimate reason to oppose)
- BUT can allowed if
- necessary to repackage
- repackaging does not adversely affect original condition
- notice to trademark owner
- indicates who repackaged
- even if all conditions met, TM owner can have legitimate reason to oppose if repackaging discredits reputation
Boehringer I
STRICT STANDARD but can repackage even if no legal bar (just consumer rejection of original is fine)
necessity:
- well-established medical prescription practice
- original packaging would face consumer resistance barring access to market
not necessity:
- commercial advantage (sell more if repackaged)
Boehringer II
NO NEED TO SHOW REPACKAGING HARMS because presumption is = inherent risk to goods
Paranova II
Applying new TM (of intended country of import)
- situation = repackaging
- apply BMS rules
- only possible if NECESSARY to penetrate
SEP v Doncaster
not necessary to apply new TM
because prescription issued under generic name
Boehringer (notice)
UK tried to argue notice not important
ECJ said NO = NOTICE IS A REAL REQUIREMENT
- must be effective and real penalty for lack of notice
- must be enough notice for TM owner to react (around 15 days if enough)
Boehringer II (notice)
not necessary to give injunction to stop resale
Bristol-Myers (discredit reputation)
consider nature of product and market of product
- pharmaceutical if directed at public = packaging crucial for public confidence
- if sold to hospital -> less important
Christian dior v Evora
DAMAGE TO MENTAL CONDITION = POTENTIALLY ACTIONABLE
- but balance must be struck between tM owner and re-seller
- seller must be able to advertise using its usual techniques
- if seller uses normal techniques, can only object if it “seriously damages reputation”
Copad v Dior
NO exhaustion of right (no consent)
IF EXHAUSTION –> would it be legitimate reasons to oppose?
- possible
- legitimate balance